Apyx Medical Corporation (APYX) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

17/25

Growth 4 Margin 3 Expansion 5 Platform 3 Financial 2

latest quarter score

Earnings Reports

17
APYX Q2 2026: Surgical Aesthetics Up 28% as AON Platform Drives Mix Shift
August 07, 2026
19
APYX Q1 2026: Aon Drives 36% Surgical Aesthetics Surge, Sets Stage for Power Lipo Expansion
May 07, 2026
19
APYX Q4 2025: Aon Drives 38% Aesthetics Surge, Setting Stage for 19% Segment Growth in 2026
March 10, 2026
19
APYX Q3 2025: Aon Launch Drives 19% Surgical Aesthetics Growth, Margin Leverage in Focus
November 06, 2025
15
APYX Q2 2025: Aon Demand Spurs $3M Guidance Hike as OEM Weakness Persists
August 08, 2025
11
Apyx Medical (APYX) Q1 2025: Advanced Energy Segment Grows 6% Amid OEM Decline and Strategic Cost Cuts
May 08, 2025
12
Apyx Medical (APYX) Q4 2024: Advanced Energy Sales Up 30% Sequentially Signal Emerging Momentum Amid Market Disruption
March 13, 2025
APYX Q3 2024: 25% Workforce Cut and $4M Cost Reduction Extend Runway, Set Up Aon Launch
November 08, 2024
APYX Q2 2024: Handpiece Sales Surge 20%+ as Generator Headwinds Persist
August 08, 2024
APYX Q1 2024: Advanced Energy Sales Drop 23% as Capital Equipment Demand Stalls
May 09, 2024
11
APYX Q4 2023: Advanced Energy Sales Up 15% as Macro Headwinds Pressure Generator Pipeline
January 08, 2024
12
APYX Q3 2023: Advanced Energy Generators Drive 70% U.S. Growth, Yet Guidance Cut on Capital Slowdown
November 09, 2023
APYX Q2 2023: Advanced Energy Sales Surge 40% as Regulatory Tailwinds Drive U.S. Momentum
August 10, 2023
APYX Q1 2023: Advanced Energy Guidance Raised as FDA Clearance Unlocks 39% Growth Path
May 11, 2023
APYX Q4 2022: Advanced Energy Down 30% as FDA Overhang Extends Recovery Timeline
March 16, 2023

Browse all companies